UMIN ID: UMIN000002369
Registered date:01/01/2010
Clinical trial on efficacy and safety of long-term Rebamipide therapy for successful eradication of Helicobacter pylori.
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Patients who successful eradication therapy of Helicobacter pylori. |
| Date of first enrollment | 2009/10/01 |
| Target sample size | 250 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | treatment group receive rebamipide 300mg three times daily for 1 year. control group do not receive rebamipide. |
Outcome(s)
| Primary Outcome | Change of histological gastritis |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1) Subjects with malignancy 2) Drug allergy 3) Severe complication 4) take non-steroidal inflammatory drugs 5) H. pylori eradication failure after first and second-line therapy. 6) Cases with unsuitable recognition by doctors |
Related Information
| Primary Sponsor | Department of Internal Medicine, division of Gastroenterology Kawasaki Medical School |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Department of Internal Medicine, division of Gastroenterology Kawasaki Medical School |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Tomoari Kamada |
| Address | 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan, Japan |
| Telephone | 086-462-1111 |
| tkamada@med.kawasaki-m.ac.jp | |
| Affiliation | Kawasaki Medical School Department of Internal Medicine, division of Gastroenterology |
| scientific contact | |
| Name | Ken Haruma |
| Address | 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan, Japan |
| Telephone | 086-462-1111 |
| tkamada@med.kawasaki-m.ac.jp | |
| Affiliation | Kawasaki Medical School Department of Internal Medicine, division of Gastroenterology |